Phase Ib Study of Rocbrutinib in Combination With R-CHOP in Patients With Newly Diagnosed B-cell Non-Hodgkin Lymphoma

NCT06251180 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

112

Enrollment

INDUSTRY

Sponsor class

Conditions

B-cell Non-Hodgkin Lymphoma

Interventions

DRUG: Rocbrutinib
BIOLOGICAL: Rituximab
DRUG: Cyclophosphamide
DRUG: doxorubicin
DRUG: Vincristin
DRUG: Prednisone

Sponsor

Guangzhou Lupeng Pharmaceutical Company LTD.